
Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it was featured on aFOXTV segment titled, "Englewoodpharmaceutical company looking to treat COVID-19 patients with... Read More
Friday April 3, 2020